Analysis of risk factors for fatal renal complications after allogeneic hematopoietic cell transplantation

被引:0
作者
Yanagisawa, Ryu [1 ]
Koyama, Hiroaki [2 ]
Yakushijin, Kimikazu [3 ]
Uchida, Naoyuki [4 ]
Jinguji, Atsushi [5 ]
Takeda, Wataru [6 ]
Nishida, Tetsuya [7 ]
Tanaka, Masatsugu [8 ]
Eto, Tetsuya [9 ]
Ohigashi, Hiroyuki [10 ]
Ikegame, Kazuhiro [11 ]
Matsuoka, Ken-ichi [12 ]
Katayama, Yuta [13 ,14 ]
Kanda, Yoshinobu [15 ]
Sawa, Masashi [16 ]
Kawakita, Toshiro [17 ]
Onizuka, Makoto [18 ]
Fukuda, Takahiro [6 ]
Atsuta, Yoshiko [19 ,20 ]
Shinohara, Akihito [2 ]
Nakasone, Hideki [15 ,21 ]
机构
[1] Shinshu Univ Hosp, Div Blood Transfus, Matsumoto, Japan
[2] Tokyo Womens Med Univ, Dept Hematol, Tokyo, Japan
[3] Kobe Univ Hosp, Dept Med Oncol & Hematol, Kobe, Japan
[4] Toranomon Gen Hosp, Dept Hematol, Federat Natl Publ Serv Personnel Mutual Aid Assoc, Tokyo, Japan
[5] Komagome Hosp, Tokyo Metropolitan Canc & Infect Dis Ctr, Hematol Div, Tokyo, Japan
[6] Natl Canc Ctr, Dept Hematopoiet Stem Cell Transplantat, Tokyo, Japan
[7] Nagoya Daiichi Hosp, Japanese Red Cross Aichi Med Ctr, Dept Hematol, Nagoya, Japan
[8] Kanagawa Canc Ctr, Dept Hematol, Yokohama, Japan
[9] Hamanomachi Hosp, Dept Hematol, Fukuoka, Japan
[10] Hokkaido Univ Hosp, Dept Hematol, Sapporo, Japan
[11] Hyogo Med Univ Hosp, Dept Hematol, Nishinomiya, Japan
[12] Okayama Univ Hosp, Dept Hematol & Oncol, Okayama, Japan
[13] Hiroshima Red Cross Hosp, Dept Hematol, Hiroshima, Japan
[14] Atom Bomb Survivors Hosp, Hiroshima, Japan
[15] Jichi Med Univ, Saitama Med Ctr, Div Hematol, Saitama, Japan
[16] Anjo Kosei Hosp, Dept Hematol & Oncol, Anjo, Japan
[17] Natl Hosp Org, Kumamoto Med Ctr, Dept Hematol, Kumamoto, Japan
[18] Tokai Univ, Dept Hematol & Oncol, Sch Med, Isehara, Japan
[19] Japanese Data Ctr Hematopoiet Cell Transplantat, Nagakute, Japan
[20] Aichi Med Univ, Sch Med, Dept Registry Sci Transplant & Cellular Therapy, Nagakute, Japan
[21] Jichi Med Univ, Ctr Mol Med, Div Emerging Med Integrated Therapeut, Shimotsuke, Japan
关键词
CHRONIC KIDNEY-DISEASE; LONG-TERM SURVIVORS; COMORBIDITY INDEX; INJURY; HCT; IMPACT; PATHOGENESIS; DYSFUNCTION; MORTALITY; GVHD;
D O I
10.1038/s41409-023-02172-4
中图分类号
Q6 [生物物理学];
学科分类号
071011 ;
摘要
Various complications can influence hematopoietic cell transplantation (HCT) outcomes. Renal complications can occur during the early to late phases of HCT along with various factors. However, studies focusing on fatal renal complications (FRCs) are scarce. Herein, we analyzed 36,596 first allogeneic HCT recipients retrospectively. Overall, 782 patients died of FRCs at a median of 108 (range, 0-3,440) days after HCT. The cumulative incidence of FRCs was 1.7% and 2.2% at one and five years, respectively. FRCs were associated with older age, male sex, non-complete remission (non-CR), lower performance status (PS), and HCT comorbidity index (HCT-CI) associated with renal comorbidity in multivariate analysis. The risk factors within 100 days included older age, multiple myeloma, PS, and HCT-CI comorbidities (psychiatric disturbance, hepatic disease, obesity, and renal disease). Older age and male sex were risk factors between 100 days and one year. After one year, HCT-CI was associated with the presence of diabetes and prior solid tumor; total body irradiation was identified as a risk factor. Non-CR was a common risk factor in all three phases. Furthermore, acute and chronic graft-versus-host disease, reactivation of cytomegalovirus, and relapse of underlying disease also affected FRCs. Systematic follow-up may be necessary based on the patients' risk factors and post-HCT events.
引用
收藏
页码:325 / 333
页数:9
相关论文
共 50 条
  • [1] Risk factors for fatal infectious complications developing late after allogeneic stem cell transplantation
    A Bjorklund
    J Aschan
    M Labopin
    M Remberger
    O Ringden
    J Winiarski
    P Ljungman
    Bone Marrow Transplantation, 2007, 40 : 1055 - 1062
  • [2] Risk factors for fatal infectious complications developing late after allogeneic stem cell transplantation
    Bjorklund, A.
    Aschan, J.
    Labopin, M.
    Remberger, M.
    Ringden, O.
    Winiarski, J.
    Ljungman, P.
    BONE MARROW TRANSPLANTATION, 2007, 40 (11) : 1055 - 1062
  • [3] Renal complications after hematopoietic stem cell transplantation
    Abboud, Imad
    Pillebout, Evangeline
    Nochy, Dominique
    NEPHROLOGIE & THERAPEUTIQUE, 2014, 10 (03): : 187 - 199
  • [4] Risk Factors for Cytomegalovirus Infection After Allogeneic Hematopoietic Cell Transplantation in Malignancies: Proposal for Classification
    Dziedzic, Magdalena
    Sadowska-Krawczenko, Iwona
    Styczynski, Jan
    ANTICANCER RESEARCH, 2017, 37 (12) : 6551 - 6556
  • [5] Lethal Pulmonary Complications After Pediatric Allogeneic Hematopoietic Stem Cell Transplantation
    Fazekas, Tamas
    Attarbaschi, Andishe
    Lawitschka, Anita
    Seidel, Markus
    Poetschger, Ulrike
    Peters, Christina
    Mann, Georg
    Gadner, Helmut
    Matthes-Martin, Susanne
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2012, 31 (02) : 115 - 119
  • [6] Neurological complications following pediatric allogeneic hematopoietic stem cell transplantation: Risk factors and outcome
    Zaidman, Irina
    Shaziri, Tamar
    Averbuch, Dina
    Even-Or, Ehud
    Dinur-Schejter, Yael
    NaserEddin, Adeeb
    Brooks, Rebecca
    Shadur, Bella
    Gefen, Aharon
    Stepensky, Polina
    FRONTIERS IN PEDIATRICS, 2022, 10
  • [7] Risk and Predictive Factors for Candidemia After Allogeneic Hematopoietic Cell Transplantation: JS']JSTCT Transplant Complications Working Group
    Kimura, Shun-ichi
    Kameda, Kazuaki
    Harada, Kaito
    Saburi, Masuho
    Okinaka, Keiji
    Shinohara, Akihito
    Uchida, Naoyuki
    Nishijima, Akihiko
    Ozawa, Yukiyasu
    Tanaka, Masatsugu
    Kuriyama, Takuro
    Katayama, Yuta
    Sawa, Masashi
    Ikegame, Kazuhiro
    Kawakita, Toshiro
    Kanda, Yoshinobu
    Nakamae, Hirohisa
    Ara, Takahide
    Kimura, Takafumi
    Sato, Atsushi
    Fukuda, Takahiro
    Atsuta, Yoshiko
    Nakasone, Hideki
    TRANSPLANTATION AND CELLULAR THERAPY, 2022, 28 (04): : 209.e1 - 209.e9
  • [8] Impact of Pretransplantation Renal Dysfunction on Outcomes after Allogeneic Hematopoietic Cell Transplantation
    Farhadfar, Nosha
    Dias, Ajoy
    Wang, Tao
    Fretham, Caitrin
    Chhabra, Saurabh
    Murthy, Hemant S.
    Broglie, Larisa
    D'Souza, Anita
    Gadalla, Shahinaz M.
    Gale, Robert Peter
    Hashmi, Shahrukh
    Al-Homsi, A. Samer
    Hildebrandt, Gerhard C.
    Hematti, Peiman
    Rizzieri, David
    Chee, Lynette
    Lazarus, Hillard M.
    Bredeson, Christopher
    Jaimes, Edgar A.
    Beitinjaneh, Amer
    Bashey, Asad
    Prestidge, Tim
    Krem, Maxwell M.
    Marks, David, I
    Benoit, Stefanie
    Yared, Jean A.
    Nishihori, Taiga
    Olsson, Richard F.
    Freytes, Cesar O.
    Stadtmauer, Edward
    Savani, Bipin N.
    Sorror, Mohamed L.
    Ganguly, Siddhartha
    Wingard, John R.
    Pasquini, Marcelo
    TRANSPLANTATION AND CELLULAR THERAPY, 2021, 27 (05): : 410 - 422
  • [9] Graft failure after allogeneic hematopoietic stem cell transplantation: Definition and risk factors
    Alcazer, Vincent
    de Latour, Regis Peffault
    Ader, Florence
    Labussiere-Wallet, Helene
    BULLETIN DU CANCER, 2019, 106 (06) : 574 - 583
  • [10] Renal thrombotic microangiopathy associated with chronic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation
    Mii, Akiko
    Shimizu, Akira
    Kaneko, Tomohiro
    Fujita, Emiko
    Fukui, Megumi
    Fujino, Teppei
    Utsumi, Kouichi
    Yamaguchi, Hiroki
    Tajika, Kenji
    Tsuchiya, Shin-ichi
    Iino, Yasuhiko
    Katayama, Yasuo
    Fukuda, Yuh
    PATHOLOGY INTERNATIONAL, 2011, 61 (09) : 518 - 527